Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00254813
Status:
COMPLETED
Last Update Posted:
2011-01-26
First Post:
2005-11-15
Brief Title:
Fast Titration Of Quetiapine Versus Currently Approved Titration
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
Fast Titration Of Quetiapine Versus Currently Approved Titration A Randomised Multicentre Parallel Group Open Trial In Schizophrenia And Schizoaffective Disorder
Status:
COMPLETED
Status Verified Date:
2011-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety and tolerability of a more rapid dose titration in acute schizophrenic patients compared to the conventional titration
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None